As we await the new drug strategy, opinion is split on how the spending cuts, funding, the coalition government and its ‘Big Society’ will make their mark on future policy. Martin Barnes picks through the evidence
As we await the new drug strategy, opinion is split on how the spending cuts, funding, the coalition government and its ‘Big Society’ will make their mark on future policy. Martin Barnes picks through the evidence